Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, June 9, 2023
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
[ Fri, Jun 09th 2023
] - WOPRAI
Thu, June 8, 2023
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
[ Thu, Jun 08th 2023
] - WOPRAI
Ed Arce Reiterated (VERA) at Strong Buy and Held Target at $10 on, Jun 8th, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Vera Therapeutics, Inc." (VERA) at Strong Buy and Held Target at $10 on, Jun 8th, 2023.
Ed has made no other calls on VERA in the last 4 months.
There are 2 other peers that have a rating on VERA. Out of the 2 peers that are also analyzing VERA, 1 agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Maintained at Hold with Increased Target to $9 on, Friday, May 12th, 2023
This is the rating of the analyst that currently disagrees with Ed
- Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $22 on, Wednesday, April 12th, 2023
